Picture of Diagnostear Technologies logo

DTR Diagnostear Technologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Diagnostear Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line-1.19-1.15-16-3.32
Depreciation
Non-Cash Items0.4590.1214.51.15
Other Non-Cash Items
Changes in Working Capital-0.14
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-0.728-1.03-1.5-2.22
Capital Expenditures-0.028-0.51500
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.0100.178-0.35
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.038-0.5150.178-0.35
Financing Cash Flow Items3.310.059
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.3731.733.640.987
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.4210.1772.2-1.52